Walsh Angela

Walsh Angela serves as the Senior Vice President of Finance at Virios Therapeutics, Inc., a biotechnology firm focused on developing treatments for viral infections. As part of her role, she oversees financial operations and strategic planning for the company. Her recent public disclosure, dated February 28, 2024, indicates a significant transaction valued at approximately $22.7K related to stock options. This disclosure marks her sole filing to date, reflecting her ongoing involvement with Virios Therapeutics, Inc. (VIRI).